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Neuronal gap junctions formed by connexin36 (Cx36) and chemical synapses share
striking similarities in terms of plasticity. Ca2+/calmodulin-dependent protein kinase II
(CaMKII), an enzyme known to induce memory formation at chemical synapses, has
recently been described to potentiate electrical coupling in the retina and several other
brain areas via phosphorylation of Cx36. The contribution of individual CaMKII isoforms
to this process, however, remains unknown. We recently identified CaMKII-β at electrical
synapses in the mouse retina. Now, we set out to identify cell types containing Cx36 gap
junctions that also express CaMKII-β. To ensure precise description, we first tested
the specificity of two commercially available antibodies on CaMKII-β-deficient retinas.
We found that a polyclonal antibody was highly specific for CaMKII-β. However, a
monoclonal antibody (CB-β-1) recognized CaMKII-β but also cross-reacted with the
C-terminal tail of Cx36, making localization analyses with this antibody inaccurate.
Using the polyclonal antibody, we identified strong CaMKII-β expression in bipolar cell
terminals that were secretagogin- and HCN1-positive and thus represent terminals of
type 5 bipolar cells. In these terminals, a small fraction of CaMKII-β also colocalized
with Cx36. A similar pattern was observed in putative type 6 bipolar cells although
there, CaMKII expression seemed less pronounced. Next, we tested whether CaMKII-β
influenced the Cx36 expression in bipolar cell terminals by quantifying the number
and size of Cx36-immunoreactive puncta in CaMKII-β-deficient retinas. However, we
found no significant differences between the genotypes, indicating that CaMKII-β is
not necessary for the formation and maintenance of Cx36-containing gap junctions in
the retina. In addition, in wild-type retinas, we observed frequent association of Cx36
Frontiers in Molecular Neuroscience | www.frontiersin.org 1 August 2019 | Volume 12 | Article 206
Tetenborg et al. CaMKII-β and Retinal Gap Junctions
and CaMKII-β with synaptic ribbons, i.e., chemical synapses, in bipolar cell terminals.
This arrangement resembled the composition of mixed synapses found for example in
Mauthner cells, in which electrical coupling is regulated by glutamatergic activity. Taken
together, our data imply that CaMKII-β may fulfill several functions in bipolar cell terminals,
regulating both Cx36-containing gap junctions and ribbon synapses and potentially also
mediating cross-talk between these two types of bipolar cell outputs.
Keywords: CaMKII, gap junction, electrical synapse, connexin36, bipolar cell, retina, cross-reactivity, antibody
INTRODUCTION
Electrical synapses in the nervous system provide a fast
route for intercellular signal transmission and fulfill several
unique functions such as cell synchronization and network
oscillations (Hormuzdi et al., 2001; Christie et al., 2005).
Structurally, electrical synapses are gap junctions made
of connexin proteins which belong to a gene family that
comprises 20 different isoforms in the mouse. Amongst
these isoforms, connexin36 (Cx36) is considered to be the
main neuronal connexin due to its high abundance in the
central nervous system (CNS), especially in the cerebellum,
the olfactory bulb and the retina, where it couples a variety
of different cell types (Bloomfield and Völgyi, 2009). The
vast majority of retinal Cx36 is expressed in AII amacrine
cells (Feigenspan et al., 2001; Meyer et al., 2014), which
integrate rod-generated signals and transmit them via
gap junctions into the cone pathway to enable scotopic
vision (Güldenagel et al., 2001; Deans et al., 2002). Apart
from the AII amacrine cell, Cx36 was also identified in
photoreceptors (Feigenspan et al., 2004; Bolte et al., 2016),
bipolar cells (Feigenspan et al., 2004; Han and Massey,
2005), ganglion cells (Schubert et al., 2005; Pan et al.,
2010), and other amacrine cells (Brüggen et al., 2015;
Yadav et al., 2019).
Accumulating evidence suggests that electrical and chemical
synapses share striking similarities in terms of plasticity and may
be regulated by the same key molecules (Pereda, 2014; Miller
and Pereda, 2017; Alcamí and Pereda, 2019). Ca2+/calmodulin-
dependent protein kinase II (CaMKII), an enzyme known to
induce memory formation, is capable of potentiating electrical
coupling in an activity-dependent manner (Alev et al., 2008;
del Corsso et al., 2012). This mechanism is quite conserved
among species (e.g., rabbit: Kothmann et al., 2012; goldfish:
Pereda et al., 1998; mouse: Turecek et al., 2014) and relies
on activation of glutamatergic synapses that are situated
in close proximity to neuronal gap junctions. Excitation of
glutamate receptors in these synapses produces a Ca2+ influx
that drives CaMKII activation and subsequent phosphorylation
of Cx36, thereby enhancing electrical coupling (Alev et al.,
2008; Flores et al., 2010; Kothmann et al., 2012). Recent
reports indicate that this pathway operates in Mauthner cells
in teleosts (Yang et al., 1990; Flores et al., 2010), neurons
of the mammalian inferior olive (Turecek et al., 2014), and
AII amacrine cells of the mammalian retina (Kothmann et al.,
2012), suggesting that CaMKII is a well conserved and essential
regulator of neuronal gap junctions in different tissues and
vertebrate classes.
Although CaMKII is considered a key molecule of synaptic
plasticity, the role of its different isoforms in modulating
electrical synapses remains unknown. Here, we studied the cell
types that contained Cx36 gap junctions and also expressed
CaMKII-β in the inner plexiform layer (IPL) of the mouse retina.
Using a polyclonal antibody, we identified CaMKII-β expression
in a subset of bipolar cell terminals and revealed that CaMKII-β
was mainly confined to gap junctions of HCN1-positive type
5 bipolar cells but was also present in putative type 6 bipolar cells.
Likely, the expression of Cx36 at these synapses does not depend
on the β-subunit as CaMKII-β deficiency did not alter the size
and number of Cx36 puncta. Also, CaMKII-β localization was
not restricted to gap junction plaques but filled large parts of
the bipolar cell terminal. Taken together, our data suggest that
CaMKII-β may be involved in plastic changes at gap junctions in
the terminals of type 5 bipolar cells and may also strongly affect
glutamate release at these terminals.
MATERIALS AND METHODS
Animals and Tissue Preparation
All procedures were approved by the local animal care committee
(Niedersaechsisches Landesamt fuer Verbraucherschutz und
Lebensmittelsicherheit) and were in compliance with the
guidelines for the welfare of experimental animals issued by
the European Communities Council Directive of 24 November
1986 (86/609/EEC) and the laws of the Federal Government
of Germany (Tierschutzgesetz; BGBl. I S. 1206, 1313 and BGBl.
I S. 1934). The experiments in this study were conducted
with C57BL/6J, Cx36+/− Cx36-EGFP mice (comparable
to Cx36+/+ Cx36-EGFP mice, see Meyer et al., 2014),
CaMKII-β+/+ and CaMKII-β−/− mice (Kool et al., 2016),
and Ier5-GFP mice (Siegert et al., 2009; Yadav et al., 2019).
Mice were deeply anesthetized with CO2 and killed by
cervical dislocation. Eyes were enucleated and dissected in
phosphate buffered saline (PBS). The cornea was removed
by cutting around the ora serrata. Afterward, the lens
and vitreous were removed and the eyecups were fixed in
2%–4% paraformaldehyde in 0.1 M phosphate buffer (PB)
for 20 min.
Constructs and N2A Cell Transfections
Transfection of N2A cells with Cx36 was carried out as previously
described in Meyer et al. (2016). Twenty-four hours prior to
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transfection 1 × 105 N2A cells were plated on 6 cm dishes in
5 ml Dulbecco’s Modified Eagle Medium (Biochrom GmbH,
Berlin, Germany), supplemented with 10% fetal bovine serum
(Biochrom). For transfection, 5 µg of DNA was mixed with the
precipitation solution and applied to N2A cells. Cells were lysed
or fixed 48 h after transfection.
Immunohistochemistry and
Immunocytochemistry
Eyecups were cryoprotected in 30% sucrose in 0.1 M PB and
embedded in TissueTek. Afterward, the retina was cut into
20 µm sections which were blocked with 10% normal goat
(NGS) or normal donkey serum (NDS) in Tris-buffered saline
(50 mM Tris/HCl, 1.5% NaCl, 0.3% Triton X-100, pH 7.4,
TBS-Tx). Primary antibodies were diluted in blocking solution
and incubated over-night at 4◦C. The following day, slices were
washed in TBST-Tx and incubated with the secondary antibodies
(conjugated to either Alexa488, Alexa568, or Alexa647, Thermo
Fisher Scientific, Waltham, MA, USA) for 2 h at room
temperature. Afterward, sections were washed with TBS-Tx and
mounted in Aqua Polymount.
Immunostainings on retinal whole-mounts were conducted
similarly, but primary and secondary antibodies were applied
for 2–3 days and 1 day, respectively, at room temperature. After
thorough washing, retina pieces were mounted in Vectashield.
For immunocytochemistry, a slightly different protocol was
used. Cells were fixed in 2% paraformaldehyde in 0.1 M PB
for 15 min at room temperature. After fixation and extensive
washing with 0.1 M PB, cells were incubated in blocking solution
containing 10% NGS in 0.1 M PB + 0.5% Tx100. Primary
antibodies were diluted in blocking solution and incubated
overnight. Secondary antibodies were incubated for 2 h at room
temperature. Coverslips were mounted in Vectashield.
Intracellular Dye Injections
Alexa Fluor 568 potassium hydrazide was injected into AII and
A8 amacrine cells in C57BL/6J and Ier5-GFP mouse retina,
respectively, as described earlier (Meyer et al., 2018; Yadav et al.,
2019). Retinal pieces from C57BL/6J mice were incubated in
0.0005% DAPI solution for 45–60 min ahead of dye injections in
order to visualize AII cell somata. In brief, sharp microelectrodes
were pulled with a Sutter P-97 puller (Sutter, Novato, CA,
USA) and typically had a resistance of 100–200 M. The
microelectrode tips were first filled with 2 µl of 10 mM Alexa
Fluor 568 potassium hydrazide and afterward backfilled with 8 µl
of 0.2 M KCl. To label AII/A8 cells, the dye was iontophoresed
with a small negative current (-1 nA, square pulses of 500 ms at
1 Hz) for 5 min. Thereafter, the dye was allowed to diffuse for
15 min ahead of the fixation.
Image Acquisition and Analysis
Images were acquired with a confocal laser scanning microscope
(Leica TCS SP8). Retinal sections and whole-mounts were
scanned with an HC PL APO CS2 63×/1.4 and 40×/1.3 objective,
respectively. The pixel size was adjusted for each experiment
and kept constant between different conditions. Step size in
Z direction was 0.16–0.5 µm. Image stacks were deconvolved
with Huygens Essential deconvolution software. Unless stated
otherwise, single confocal scans are shown.
Stacks were adjusted for contrast and brightness in Fiji1
(Schindelin et al., 2012). For presentation purposes, some images
were saturated in brightness to allow for better visibility of
the small immunoreactive structures. For colocalization analyses
saturation was avoided.
Quantification of Cx36-immunoreactive puncta expressed on
bipolar cell terminals was performed with the Colocalization
Highlighter plugin in Fiji. Both image stacks (six confocal
scans, 0.2 µm each) were thresholded using the Auto Threshold
function. Colocalized puncta were maximum projected. A region
of interest (ROI, 23× 5.4 µm2) was placed at the border between
OFF and ON layers and puncta were measured in terms of
frequency and size. Puncta smaller than 8 pixels2 were excluded
from quantification.
Quantification of immunostainings in retinal whole-mounts
was performed as described recently (Yadav et al., 2019),
with slight modifications: in a ROI (48 × 48 × 5 µm3),
we first estimated colocalization for CtBP2 and Cx36, using
the Colocalization Highlighter plugin in Fiji. The resulting
colocalized puncta were checked for additional colocalization
with CaMKII-β. Colocalization was then checked by sequential
3D-rotation of the stack as described in Yadav et al. (2019). Please
note that the colocalization obtained by using the Colocalization
Highlighter was only slightly overestimated when compared to
the 3D-rotation analysis. As it was not feasible to apply the
3D-rotation analysis to the hundreds of CtBP2 and Cx36 puncta
present in the ROI, we carried out this analysis only for
the triple colocalization as the numbers were expected to be
much smaller.
Protein Purification and
Immunoprecipitation and Western Blot
Plasmids encoding the intracellular domains of Cx36 were cloned
into pGEX6P2 vector, allowing for N-terminal tagging with
GST. Proteins were expressed in BL21 cells. Expression was
induced with 1 mM isopropyl-β-D-thiogalactopyranoside. After
expression, cells were lysed with lysozyme and insoluble material
was removed by centrifugation at 17,000 rpm for 40 min at
4◦C. The supernatant was applied to a glutathione sepharose
column and incubated overnight at 4◦C. After extensive washing
with binding buffer [containing 150 mM NaCl, 50 mM Tris
(pH 7.4), 10 mM dithiothreitol], GST-fusion proteins were
eluted from the column with elution buffer [containing 150 mM
NaCl, 50 mM Tris (pH 7.4), 10 mM dithiothreitol and 10 mM
reduced glutathione]. Immunoprecipitation (IP) was carried out
as previously described in Meyer et al. (2016). For crosslinking
of CB-β-1, 1–2 µg of antibody were applied to 50 µl magnetic
protein G beads (Miltenyi Biotec GmbH, Bergisch Gladbach,
Germany) and incubated for 15 min in 20 mM dimethyl
pimelimidate (diluted in tri-ethonalamine, pH 8). Retinas were
dissected as described above and homogenized in IP buffer,
containing 0.5% NP-40, 50 mM Tris (pH 7.4), 150 mM NaCl
and phosphatase and protease inhibitors (Roche Diagnostics,
1https://fiji.sc/
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Mannheim, Germany). The lysate was incubated for 1 h on ice
and centrifuged for 10 min at 10,000 g at 4◦C. The supernatant
was removed and precleared with protein G beads. Afterward, the
lysate was incubated with previously prepared CB-β-1 beads for
2 h. After several washes, proteins were eluted with elution buffer,
containing 50 mM Tris HCl (pH 6.8), 50 mM dithiothreitol, 1%
SDS, 1 mM EDTA, 0.005% bromophenol blue, and 10% glycerol.
SDS-PAGE (10% gels) and western blot were performed with
homogenates and IP samples. Enhanced chemiluminescence
was carried out as previously described in Meyer et al. (2016).
Nitrocellulose membranes were blocked in 5% milk powder in
TBS-Tween (20 mM Tris/HCl, 150 mM NaCl, 0.2% Tween, pH
7.4) and incubated with the respective antibody overnight at
4◦C. Immunoreactive proteins were detected with a horse radish
peroxidase-conjugated secondary antibody (Biorad Laboratories;
1:2,000–1:3,000 diluted in 2% milk powder in TBS-Tween) and
an Enhanced chemiluminescence detection kit (Thermo Fisher
Scientific, Waltham, MA, USA).
Statistical Analysis
Data is presented as mean ± standard deviation (SD) or as
boxplots, representing the mean (central black line), the upper
and lower quartile (bottom and top boundaries of the box), and
the largest and lowest values in the dataset that are not outliers
(whiskers). Differences were tested for statistical significance
using a Mann–Whitney U test (GraphPad Prism 6) at an α level
of 0.05. Quantitative data were always obtained from at least three
different mice.
RESULTS
The Monoclonal Anti-CaMKII-β Antibody
CB-β-1 Detected a Protein in Addition to
CaMKII-β
In the mammalian retina, CaMKII has been shown to increase
homologous coupling between AII amacrine cells (Kothmann
et al., 2012). A recent study in our lab suggests that this
effect may be mediated by a particular CaMKII isoform:
CaMKII-δ (Tetenborg et al., 2017). Our experiments further
revealed colocalization of Cx36 and a second CaMKII isoform
(CaMKII-β), suggesting that CaMKII and Cx36 interact
in an additional unidentified retinal neuron. Therefore,
we set out to determine the localization of CaMKII-β at
electrical synapses in the inner retina. First, we tested the
specificity of two commercially available antibodies for
CaMKII-β, a monoclonal from Thermo Fisher Scientific,
Waltham, MA, USA (CB-β-1) and a polyclonal from abcam
(34703, Table 1) on CaMKII-β knockout retinas. In wild-type
retinas, both antibodies displayed a punctate staining in
the IPL and labeled the outlines of somata in the INL
(arrows Figures 1A,C,E). However, in CaMKII-β knockout
retinas, the punctate CB-β-1 labeling in the IPL partially
remained (Figures 1B,F), indicating cross-reactivity with an
unknown protein. In contrast, the immunoreactivity of the
polyclonal antibody (abcam) almost completely vanished
(Figure 1D), suggesting that this antibody is specific for
CaMKII-β.
These results were confirmed with western blot analysis
comparing retina and cerebellar tissue from wild-type and
CaMKII-β-deficient mice (Figures 1G,H). The polyclonal
antibody from abcam recognized two proteins in retina and three
proteins in cerebellar samples with molecular masses around the
predicted sizes (49–60 kDa) for CaMKII-β splice variants (Wang
et al., 2000). These bands were not detected in knockout tissue,
confirming the specificity of the abcam antibody (Figure 1G). In
contrast and consistent with the immunohistochemical stainings,
the CB-β-1 antibody showed only a single band for CaMKII-β
but also prominent bands which persisted in CaMKII-β-deficient
tissue (Figure 1H), suggesting that this antibody recognizes an
additional protein.
CB-β-1 Antibodies Cross-Reacted With
Cx36 and Recognized Its C-Terminal Tail
The remaining CB-β-1 immunoreactivity in CaMKII-β-deficient
retinas resembled the appearance of Cx36 in confocal scans in
terms of puncta size and density in the proximal IPL. This result
raised the question whether CB-β-1 actually recognized Cx36. To
address this, we transfected N2A cells with Cx36 and Cx36-EGFP
and tested for binding of CB-β-1 using immunocytochemistry
and western blot (Figure 2). Indeed, the CB-β-1 antibody
labeled gap junctions in Cx36 transfectants (Figure 2A, arrows).
Cx36 and CB-β-1 antibodies detected the same band in
Cx36-transfected N2A cells (Figure 2B, arrow), which was
not present in lysates from untransfected and empty vector-
transfected cells.
To further investigate the cross-reactivity of CB-β-1
antibodies on retinal tissue, we cross-linked CB-β-1 antibodies
to magnetic protein G beads and performed an IP. We found
that CB-β-1 antibodies precipitated two proteins: CaMKII-β
(Figure 2C, short arrow, also detected with the polyclonal
anti-CaMKII-β antibody from abcam) and—though very
weakly—Cx36 (Figure 2C, long arrow, also detected with
TABLE 1 | List of antibodies used in this study.
Antibody Host, type Dilution Source Cat. (No.)
CaMKII-β, clone: CB-β-1 Mouse, monoclonal 1:500 Thermo Fisher Scientific, 13-9800
CaMKII-β Rabbit, polyclonal 1:1,000, 1:500 (WM) abcam, 34703
Cx36, clone: 1E5H5 Mouse, monoclonal 1:500, 1:250 (WM) Thermo Fisher Scientific, 37-4600
Cx36 Rabbit, polyclonal 1:500 Thermo Fisher Scientific, 36-4600
CtBP2 Mouse, monoclonal 1:500, 1:100 (WM) BD Transduction Laboratories, 612044
HCN1, Clone: N70/28 Mouse, monoclonal 1:100–200 NeuroMab, 75-110
WM gives the concentration used in retinal whole-mount stainings.
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FIGURE 1 | Monoclonal anti-Ca2+/calmodulin-dependent protein kinase II (CaMKII)-β antibodies (CB-β-1) detected CaMKII-β but also an additional protein in the
retina. (A–F) Immunolabeling for CaMKII-β with two different antibodies, a monoclonal from Thermo Fisher Scientific, Waltham, MA, USA (CB-β-1, A,B,E,F) and a
polyclonal from abcam (CaMKII-β abcam; C–F) in wild-type (A,C,E) and CaMKII-β-deficient mice (B,D,F). Punctate staining remained in CaMKII-β-deficient animals
when using the CB-β-1 antibody but was almost completely gone with the abcam antibody. Both antibodies showed substantial overlap in cell bodies (long arrows in
A,C,E) but only weak overlap in the inner plexiform layer (IPL, small arrows in inset of A,C,E). Scale: 10 µm. (G,H) Western blots revealed that the anti-CaMKII-β
antibody from abcam (G) recognized two different bands (asterisks) in wild-type retina which were not detected in CaMKII-β knockout tissue, confirming the
specificity of the abcam antibody. In contrast, CB-β-1 antibodies recognized only a single band for CaMKII-β (asterisks) but several bands appeared which also
occurred in CaMKII-β knockout tissue.
monoclonal antibodies for Cx36). These results were consistent
with the labeling we observed in transfected N2A cells and the
retina. Thus, we conclude that the CB-β-1 antibody recognizes
CaMKII-β but also cross-reacts with Cx36.
To provide the final proof and also determine the epitope
for CB-β-1 binding on Cx36, we generated and purified
the cytoplasmic loop and C-terminal tail of Cx36 and fused
them to a GST-protein. Then, we tested for CB-β-1 binding.
Indeed, the CB-β-1 antibody recognized the C-terminal tail
(Figure 2D, arrow) but not the cytoplasmic loop of Cx36
(Figure 2D, asterisks). The CB-β-1 antibody showed the
same binding pattern as the monoclonal Cx36 antibody,
which was used as positive control because it is known to
bind to the C-terminal tail of Cx36 (Figure 2D; Hilgen
et al., 2011). Taken together, this data confirmed that
the monoclonal CaMKII-β antibody CB-β-1 specifically
recognized Cx36 and bound to its C-terminal tail in
retinal tissue.
Colocalization of CaMKII-β and Cx36 Was
Predominantly Detected in the Middle of
the IPL
To determine the synaptic localization of CaMKII-β in the
IPL of the mouse retina, we used only the polyclonal
antibody for CaMKII-β from abcam. We double-labeled retinas
for secretagogin (SCGN), a marker for a subset of cone
bipolar cells (Puthussery et al., 2010). CaMKII-β labeling was
detected in the entire IPL but was very strongly expressed
in bipolar cell terminals that stratified in the middle layer
of the IPL (Figures 3A–I). This was confirmed by labeling
retinal whole-mounts for CaMKII-β and VGluT1, a marker
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FIGURE 2 | The anti-CaMKII-β antibody CB-β-1 cross-reacted with the
C-terminal tail of connexin36 (Cx36). (A,B) Expression of Cx36 in N2A cells.
CB-β-1 antibodies recognized Cx36 in transfected N2A cells in
immunocytochemical stainings (A, arrows) and western blot experiments
(B, arrow). It probably also recognized endogenous CaMKII-β expressed in
N2A cells (asterisk). (C) Immunoprecipitation (IP) from retinal lysates using
CB-β-1 antibodies revealed their binding to CaMKII-β and Cx36 whereas the
CaMKII-β antibody from abcam (abc.) only detected CaMKII-β, as expected.
(D) Binding of CB-β-1 antibodies to the purified C-terminal tail of Cx36
(arrow). Asterisks denote the expected band for the cytoplasmic loop, which
was not detected by CB-β-1 and Cx36 antibodies. Scale: 20 µm.
for all bipolar cell terminals. In the middle of the IPL,
strong CaMKII-β labeling was detected in and surrounding
bipolar cell terminals (Figures 3J–K”’, arrows). Moreover, the
strong CaMKII-β labeling in that region partially colocalized
with HCN1 (Figures 3L–T), a marker for type 5 bipolar
cells (Müller et al., 2003; Hellmer et al., 2016), suggesting
that CaMKII-β expression is strong in type 5 bipolar cells.
These bipolar cells form four subtypes (Tsukamoto and Omi,
2017) but because subtype-specific markers were not available,
we could not ascribe this strong CaMKII-β expression to a
particular subtype of type 5 bipolar cells. Please note that
colocalization with SCGN was also found for bipolar cell
terminals in the proximal IPL, which presumably represent type 6
bipolar cells.
In Tetenborg et al. (2017), we identified colocalization
of CaMKII-β and the gap junction protein Cx36 in a
region that corresponded to the third sublamina of the IPL.
Therefore, we tested for CaMKII-β/Cx36 colocalization on type
5 bipolar cells and triple-labeled retinas for Cx36, CaMKII-β
and either SCGN (Figures 4A–D) or HCN1 (Figures 4E–J).
These stainings revealed substantial colocalization of Cx36 and
CaMKII-β on type 5 bipolar cell terminals (arrows in
Figures 4B’–C””, F’–G””). Line scans that were obtained
from individual gap junction plaques confirmed the close
association of Cx36, CaMKII-β and the respective bipolar cell
marker (Figures 4D,H). A maximum projection of highlighted
Cx36/CaMKII-β colocalization demonstrates that puncta were
mainly confined to the middle of the IPL (Figure 4I). Merging a
single scan of this binary image with HCN1, it became visible that
colocalized puncta were predominantly situated on the terminals
of HCN1-positive type 5 bipolar cells (Figure 4J).
Retinal whole-mounts labeled for CaMKII-β, Cx36 and
VGluT1 (a marker for all bipolar cell terminals), gave
similar results: in the middle of the IPL, CaMKII-β
immunolabeling almost filled the VGluT1-positive terminals
and partially colocalized with Cx36-immunoreactive puncta
(Figures 4K–M””, arrows). In addition, quantification analysis
on Cx36-EGFP-positive whole-mount retinas revealed that
24 ± 2% of all Cx36-EGFP-immunoreactive puncta in the
middle of the IPL colocalized with CaMKII-β, whereas only
6 ± 1% of all CaMKII-β-immunoreactive structures colocalized
with Cx36-EGFP (Table 2; data are given as mean ± SD, from
three mice).
Please note that the middle of the IPL also contained
colocalized Cx36 and CaMKII-β immunoreactivity that was not
associated with bipolar cell terminals. These puncta can probably
be assigned to gap junctions on amacrine or ganglion cells.
Taken together, our data imply that CaMKII-β and
Cx36 colocalize at type 5 bipolar cell terminals and presumably
to a smaller degree on type 6 bipolar cells. However, as only a
small fraction of the CaMKII-β immunoreactivity contributes to
this colocalization, our data suggest that CaMKII-β may fulfill
several functions at bipolar cell synapses.
CaMKII-β and Cx36 Were Closely
Associated With Synaptic Ribbons on
Bipolar Cell Terminals
Kothmann et al. (2012) showed that gap junctions in AII
amacrine cells are modulated via non-synaptic NMDA receptors
that are activated by glutamate spillover from a neighboring
chemical synapse. Our observation, however, might point to a
different mechanism for CaMKII signaling as we found most
Cx36/CaMKII-β puncta directly inside bipolar cell terminals.
This localization suggests that Cx36 and CaMKII-β may be
located in close vicinity to the glutamate release site. To confirm
this hypothesis, we additionally labeled for ribbon synapses
with antibodies directed against the C-terminal binding protein
2 (CtBP2). We found Cx36 and CaMKII-β to be marginally
colocalized with synaptic ribbons because less than 1% of all
CtBP2 puncta showed additional Cx36 and CaMKII-β labeling
(Figures 5A–E, short arrows; Table 2). However, we did find that
many Cx36/CaMKII-β-immunoreactive puncta were in close
association with synaptic ribbons in type 5 bipolar cells, as was
revealed by additional labeling for SCGN (Figures 5F–J, arrows
in insets). Thus, despite the lack of colocalization, the close
association of Cx36, CaMKII-β and glutamatergic synapses could
allow for activity-dependent potentiation of electrical synapses in
bipolar cells.
Do Cx36/CaMKII-β-Colocalized Puncta
Represent Contacts to AII and
A8 Amacrine Cells?
Above, we have shown that a low amount of CaMKII-β
colocalized with Cx36 in type 5 (and presumably type 6) bipolar
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FIGURE 3 | Association of CaMKII-β with terminals of type 5 bipolar cells. (A–I) CaMKII-β labeling (abcam antibody) was especially strong in an SCGN-positive
bipolar cell type that stratified in the middle of the IPL. Weaker colocalization was also on bipolar cell terminals that were located more proximally, and likely represent
type 6 ON bipolar cells. (J–K”’) A retinal whole-mount, labeled for CaMKII-β and VGluT1, was scanned in the middle of the IPL. VGluT1-labeled bipolar cell terminals
were prominently decorated with CaMKII-β immunoreactive puncta. (L–T) CaMKII-β immunoreactivity was tightly associated with terminals of type 5 bipolar cell
terminals, which were labeled with HCN1. Scale: (A–C,L–N), 10 µm; (D–I,J,K’–K”’,O–T), 5 µm.
cell terminals. Next, we tried to determine the gap junctional
partner at these sites. First, we tested for AII amacrine cells
because these cells were shown to couple to type 5 and 6 bipolar
cells (Veruki and Hartveit, 2002; Tsukamoto and Omi, 2017).
We injected AII cells in C57BL/6J retinas with Alexa 568 and
additionally labeled the whole-mounts for SCGN, CaMKII-β
and Cx36. We found Cx36 to be present on the dendrites of
the injected AII cell and opposed to SCGN-positive bipolar
cell terminals (Figures 6A–C””, arrows). However, on AII
dendrites Cx36 did not colocalize with CaMKII-β, indicating
that Cx36/CaMKII-β-containing gap junctions are not present
on AII cells.
In addition, we Alexa 568-injected A8 amacrine cells in
the Ier5-GFP line because these cells are also coupled to ON
bipolar cells in the mouse retina (Lee et al., 2015; Yadav et al.,
2019). Cx36/CaMKII-β colocalization on SCGN-positive bipolar
cell terminals occurred separated from dye-filled dendrites of
A8 cells (Figures 6D–F””, arrows), suggesting that CaMKII-β
does not regulate the coupling between A8 amacrine and
ON bipolar cells. Conversely, these results imply that type
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FIGURE 4 | Colocalization of CaMKII-β and Cx36/Cx36-EGFP on terminals
of type 5 bipolar cells. (A–C””) Cx36-EGFP and CaMKII-β immunoreactivity
(abcam antibody) mainly colocalized on SCGN-labeled terminals of bipolar
cells. (D) A line scan revealed close proximity of Cx36-EGFP and CaMKII-β
on bipolar cell terminals. The line scan was taken from the area marked
as (C). (E–G””). Triple stainings with HCN1 revealed that Cx36-EGFP and
CaMKII-β mainly colocalized on terminals of type 5 bipolar cell terminals,
stratifying in sublamina 3. (H) Line scan of all three channels shown in (G). (I)
Maximum projection of the highlighted Cx36-EGFP/CaMKII-β colocalization.
(J) Merged single scans of highlighted Cx36-EGFP/CaMKII-β colocalization
and HCN1. (K) Maximum projection (32 slices) of a retinal whole-mount,
triple-labeled with CaMKII-β, Cx36 and VGluT1. (L–M””) Magnified bipolar
cell terminals revealed Cx36 and CaMKII-β colocalization. Scale: (A,E,I–K),
10 µm; (B’–C””,F’–G””,L’–M””), 2.5 µm.
5 bipolar cells may make Cx36-containing gap junctions with
an unknown cell type and these gap junctions may be regulated
by CaMKII-β.
CaMKII-β Deficiency Did Not Alter
Cx36 Expression in Bipolar Cell Terminals
A recent study implies that CaMKII-β but not CaMKII-α is
essential for electrical synapse formation in the inferior olive
(Bazzigaluppi et al., 2017), contrasting previous results from
Kothmann et al. (2012) who showed that CaMKII inhibition
disrupts Cx36 phosphorylation but not the formation of Cx36-
containing gap junctions. Our observations so far indicated
that CaMKII-β expression occurred at gap junctions in type
5 bipolar cells, which raised the question whether this isoform
fulfills a similar function as in the inferior olive and mediates
gap junction formation in these neurons. We tested this
hypothesis and determined the size and number of Cx36 puncta
on SCGN- (Figures 7A–J) and HCN1-positive bipolar cells
(Figures 7K–T) of control and CaMKII-β-deficient retinas. To
estimate Cx36 puncta expressed in type 5 bipolar cells, we placed
a ROI in the middle of the IPL. However, the total number
and size of Cx36 were almost unchanged, as was the degree of
colocalization with bipolar cell markers (Figures 7I,J,S,T). The
only significant difference (p = 0.0247) we found was in the size
of the Cx36 puncta (Figure 7T) in samples that were also labeled
for HCN1. But given the lack of a difference on SCGN-labeled
terminals (Figure 7J) the significance of this finding is unclear.
Our analysis led us to conclude that CaMKII-β is not necessary
for the formation of electrical synapses in the terminals of type
5 bipolar cells.
DISCUSSION
Interaction of CaMKII-β and Cx36 on Type
5 Bipolar Cell Terminals
Although CaMKII is considered as a key molecule of synaptic
plasticity, the role of its different isoforms in modulating
electrical synapses remains unknown. Our lab recently
demonstrated that among the four CaMKII isoforms, only
the β- and -δ subunits associate with gap junctions in the
retina (Tetenborg et al., 2017). Interestingly, CaMKII-β and
CaMKII-δ are differentially associated with gap junctions in
the murine retina: CaMKII-β is predominantly found in the
outer retina, whereas CaMKII-δ is associated with Cx36 in AII
and TH2 amacrine cells. Likewise, the localization with respect
to glutamatergic synapses differs between the two isoforms:
CaMKII-β is strongly expressed postsynaptically to rod bipolar
cell terminals, whereas CaMKII-δ is found close to photoreceptor
synaptic ribbons and inside rod bipolar cell terminals. Here,
we demonstrate that the terminals of HCN1-positive type
5 bipolar cells are an exception to this pattern; they expressed
large amounts of CaMKII-β inside the terminal where it
partially colocalized with Cx36 and CtBP2. This suggests that:
(1) CaMKII-β may have a similar function for type 5 cells
as CaMKII-δ for rod bipolar cells; and (2) CaMKII subunit
composition at gap junctions is cell type-specific although we
cannot entirely exclude that the two CaMKII isoforms are
expressed in overlapping cell populations.
Some of the four subtypes of type 5 bipolar cells are
known to form gap junctions with AII amacrine cells
(Tsukamoto and Omi, 2017). This is also true for type
6 bipolar cells, which additionally couple to A8 amacrine
cells (Yadav et al., 2019). However, the Cx36/CaMKII-
colocalized puncta, associated with type 5 (and to a lesser
degree type 6) bipolar cell terminals, were not located
on AII or A8 amacrine cells, ruling out both small-field
amacrine cells as coupling partners. Thus, it is intriguing
to speculate that there is at least one additional synaptic
partner coupled to type 5 cells. As type 5 cells also show
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TABLE 2 | Quantification of CaMKII-β/Cx36 colocalization in the middle of the IPL.
Cx36 CaMKII Cx36/CaMKII CtBP2 Cx36/CaMKII/CtBP2
Overall puncta 553 ± 98 2,362 ± 101 2,194 ± 409
Colocalized puncta 130 ± 12 7 ± 3
% colocalization 24 ± 2 6 ± 1 <1 1 ± 1
No. of mice 3 3 3 3 3
CaMKII denotes CaMKII-β. Values are given as mean ± SD.
FIGURE 5 | CaMKII-β immunoreactivity and Cx36-EGFP were closely associated with synaptic ribbons on bipolar cell terminals. (A–D””) Triple stainings revealed
close proximity of CaMKII-β (abcam antibody), Cx36-EGFP and CtBP2 on SCGN-positive bipolar cell terminals. (E) Line scans of the individual gap junction plaque
shown in (B). (F–J) Cx36-EGFP expression and triple labeling for CaMKII-β, CtBP2 and SCGN. Scale: (A), 10 µm; (B–D””), 2.5 µm; (F–J), 5 µm.
across-subtype coupling (Tsukamoto and Omi, 2017),
CaMKII-β may regulate the coupling between bipolar cells.
However, as dye injections into bipolar cells are very difficult,
we could not study inter-bipolar cell coupling systematically. But
in one instance, when we dye-injected a type 5 bipolar cell, we
detected Cx36 colocalized with CaMKII-β at a contact point of
two bipolar cell dendrites in layer 3 of the IPL (Supplementary
Figure S1). This may represent heterologous coupling between
different type 5 bipolar cell subtypes, as was reported before
(Tsukamoto and Omi, 2017).
Neuronal gap junctions are not as static as previously
thought and the efficacy of these synapses can be dynamically
modulated by interaction with glutamatergic synapses (reviewed
in Pereda, 2014). In the retina, CaMKII was shown to mediate
a signaling cascade that changes the phosphorylation state
of Cx36 in AII amacrine cells (Kothmann et al., 2012).
The activation of CaMKII is initiated by Ca2+ entry via
extra-synaptic NMDA receptors. Here, we found CaMKII-β
and Cx36 colocalization on bipolar cell terminals. Although
CaMKII-β/Cx36-colocalized structures did not colocalize with
CtBP2, the ribbon marker, the close association with the
glutamate release site may allow for activity-dependent plasticity
and crosstalk between electrical and chemical synapses in the
same bipolar cell terminal.
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FIGURE 6 | CaMKII-β was absent from gap junctions that AII and
A8 amacrine cells form with bipolar cells. (A) XZ rotation of an
Alexa568-injected AII amacrine cell. Please note that the “whirl” around the
soma represents an injection artifact. (B) Maximum projection (20 optical
sections) of the injected cell, labeled for CaMKII-β, Cx36, and SCGN.
(C’–C””) Colocalization of Cx36 and SCGN was associated with processes
of the injected AII amacrine cell but not with CaMKII-β immunoreactivity.
(D–F””) Same as (A–C””) but showing an Alexa568-injected A8 amacrine
cell. Colocalization of Cx36 and CaMKII-β (indicated by arrows) was not
associated with processes of the injected A8 amacrine cell.
Cx36 immunoreactivity on the A8 dendrite was not associated with CaMKII-β
(arrowhead). Scale: (A,B,D,E), 10 µm; (C’–C””,F’–F””), 2.5 µm.
CaMKII-β and Electrical Synapse
Formation
Our data indicate that CaMKII-β is not required for electrical
synapse formation in the mouse retina because genetic deletion
of this subunit had no effect on the number and size of
Cx36-immunoreactive puncta on bipolar cell terminals. This
was also corroborated by the fact that only a subset of
Cx36-containing gap junctions colocalized with CaMKII-β in the
mouse retina (this study; Tetenborg et al., 2017). In contrast,
Cx36 and CaMKII were reported to strongly overlap in the
murine inferior olive (Alev et al., 2008); and Bazzigaluppi et al.
(2017) showed that genetic deletion of CaMKII-β reduces the
density of Cx36 immunoreactivity in this brain area. Thus,
CaMKII-β presumably fulfills a critical function in gap junction
stability in one part of the CNS (inferior olive) but not in
another (retina). As genetic ablation of CaMKII-β did not
induce any alterations in gap junction size and frequency, we
assume that the role of this subunit for retinal gap junctions
is to modulate channel gating but not gap junction formation
or maintenance.
What Does Cause the Cross-Reaction of
CB-β-1 With Cx36?
One interesting aspect of this study was that we uncovered a
cross-reaction of CB-β-1 with the C-terminal tail of Cx36. This
was completely unexpected as the antibody has been widely used
in a variety of different publications (Liu and Cooper, 1996;
Brigman et al., 2010; Kool et al., 2016). Presumably, this cross-
reaction was overseen because most research on CaMKII focuses
on chemical synapses and long-term potentiation, and no other
lab so far investigated distinct CaMKII subunits in relation to
electrical synapses. Moreover, Cx36 tends to dimerize when the
protein samples are boiled prior to gel electrophoresis. This
often results in a western blot band of similar height than the
CaMKII-β band, making confusions likely.
Still, it is intriguing that CaMKII-β and Cx36 do interact and
can be recognized by the same antibody although both molecules
belong to completely different protein families, serine/threonine
kinases and ion channels, respectively. The epitope of CB-β-
1 is unknown as the entire CaMKII-β protein was initially
used for immunization, allowing us to only hypothesize what
actually may have caused this cross-reaction. A previous study
from Alev et al. (2008) reported that CaMKII interacts with
Cx36 in a similar way as it does with glutamate receptors.
This study further indicated a sequence similarity between
the C-terminal tail of Cx36 and the auto-inhibitory region
of CaMKII. If this very region represented the epitope for
the monoclonal CB-β-1 antibodies, its sequence similarity to
Cx36 could explain the cross-reactivity we observed. Consistent
with this hypothesis, CB-β-1 antibodies recognized the isolated
C-terminal tail but not cytoplasmic loop of Cx36. However, the
amino acid sequence in question is also present in CaMKII-α
but we did not observe any cross-reactivity with the α-subunit
in retinal sections (personal observation S. Tetenborg; see also
Tetenborg et al., 2017), although minor binding of CB-β-1 to
CaMKII-α is known from western blots (personal observation
S. Tetenborg; see also Thermo Fisher Scientific, Waltham, MA,
USA, data sheet). At the very least, this finding once more
confirms that knockout tissue is essential to definitely test the
specificity of an antibody.
In summary, our data adds to the growing body of
evidence that electrical and chemical synapses share many
features (here: modulation by CaMKII-β). The differential and
distinct expression pattern of CaMKII isoforms may provide the
molecular basis for the fine-tuning of glutamate release and gap
junctional coupling in retinal bipolar cells. It may even represent
a substrate for extensive crosstalk between the two means of
synaptic transmission.
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FIGURE 7 | CaMKII-β deficiency did not affect puncta size and frequency of Cx36 clusters on bipolar cell terminals in the mid-IPL. (A–H) Comparison of
Cx36 puncta expression on SCGN-positive bipolar cell terminals between WT and CaMKII-β KO retinas. Colocalized puncta shown in (A–D) are highlighted in white
in (E–H). (I,J) Quantitative analysis of Cx36-immunoreactive puncta colocalizing with SCGN. We did not find any significant differences between genotypes
(Mann–Whitney U test, n = 22 ROIs from three mice for each genotype, p > 0.23 for all comparisons). (K–R) Testing for Cx36 immunoreactivity on HCN1-labeled
bipolar cell terminals. Colocalized puncta are highlighted in white. (S,T) Analysis of colocalized puncta revealed no differences in cluster frequency and size between
genotypes (Mann–Whitney U test, n = 21/23 ROIs from three mice for control/CaMKII-β-deficient mice, p > 0.0674 for all comparisons). Only a slight difference in the
average size of all Cx36 puncta was detected (Mann–Whitney U test, p = 0.0247), which was not present in double stainings with SCGN (J). n.s. denotes
non-significant; *p < 0.05. Scale: (A,B,E,F,K,L,O,P), 10 µm; (C,D,G,H,M,N,Q,R), 5 µm.
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